# The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia

> **NCT01717625** · PHASE2 · COMPLETED · sponsor: **Ajou University School of Medicine** · enrollment: 72 (actual)

## Conditions studied

- Premature Birth
- Infant, Very Low Birth Weight
- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Montelukast

## Key facts

- **NCT ID:** NCT01717625
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-02-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01717625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01717625, "The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01717625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*